Product Overview
• Prescription fixed-dose combination antihypertensive • Contains 20 mg olmesartan medoxomil + 5 mg amLodipine (as besylate) per film-coated tablet • Dual-action: angiotensin II receptor blocker (ARB) + calcium channel blocker (CCB) • Once-daily dosing for powerful blood pressure control • Pack of 28 tablets (4-week supply) • Requires a doctor’s prescription
Product Description
Sevikar 20/5 mg combines olmesartan, a highly effective ARB that blocks the vasoconstricting effects of angiotensin II, with amLodipine, a long-acting calcium channel blocker that relaxes blood vessels. This synergistic combination provides superior 24-hour blood pressure reduction compared to either drug alone, especially in patients with moderate to severe hypertension not adequately controlled on monotherapy. It offers smooth onset, excellent tolerability, and significant reduction in cardiovascular risk. Benefits • Greater blood pressure lowering than olmesartan or amLodipine alone • Effective 24-hour control with once-daily dosing • Reduces risk of stroke, heart attack, and kidney damage • Low incidence of ankle swelling compared to higher-dose amLodipine • Well tolerated with minimal metabolic side effects • Convenient single-tablet regimen improves adherence • Proven efficacy in difficult-to-treat hypertension How to Use • Take one tablet once daily, at the same time each day • Swallow whole with water; can be taken with or without food • Usual starting and maintenance dose: 20/5 mg daily • Can be increased to 40/5 mg or 40/10 mg if further control needed • Regular blood pressure and kidney function monitoring recommended • Do not stop suddenly without medical advice • Avoid grapefruit juice (may increase amLodipine effect)